希少疾患向け医療用食品の市場規模、シェア、動向分析レポート：投与経路別、製品別、用途別（チロシン血症、MSUD、ホモシスチン尿症）、販売チャネル別、地域別、セグメント別予測、2023年～2030年

希少疾患向け医療用食品市場の成長と動向

希少疾患向け医療用食品の世界市場規模は、2030年までに19億米ドルに達すると予測されています。グランドビューリサーチ社の新しいレポートによると、2022年から2030年にかけてCAGR5.5％で拡大すると予想されています。業界の成長に寄与する主な要因は、希少疾患の有病率の上昇と、そうした希少疾患に対する認知度の向上です。さらに、早期スクリーニングに対する政府の取り組みの高まりや、そうしたニッチなセグメントに対応する製品を開発する主要企業の取り組みの増加も、成長の有望な展望を告げています。

さまざまな希少疾患では、重大な障害を予防し、子供や大人の正常な成長を可能にするために、特別な医療用栄養が必要とされます。食品タンパク質によるメープルシロップ尿症、短腸症候群などの疾患では、堅牢な健康を維持するために特別な食事が必要とされます。このような稀な疾患に対する認識が高まり、食事療法の有効性が高まったことで、さらなる成長の道筋が期待されています。

医療用食品は高価であり、健康保険が適用される場合とされない場合があります。FDAは薬用食品を医薬品として分類していないため、多くの保険制度が薬用食品を対象としていないです。これは予測期間中の市場拡大の妨げになる可能性があります。

他の産業とは異なり、COVID-19は市場成長にプラスの影響を与えました。免疫と健康食品に関する意識の高まりにより、臨床食品の採用率が大幅に上昇しました。2020年には、2019年と比較して、消費者は栄養サポートと食事療法を包含するはるかに健康的なダイエットを選んでいます。

経口セグメントは、2022年に69.5％を超える収益シェアを獲得し、市場を独占しました。薬用食品の経口ルートは、最も便利で手間がかからないことに変わりはありません。したがって、世界的に消費者に最も好まれるルートであり続け、経口製品は容易に入手できます。錠剤、粉末、増粘剤などの形態で経口製品の生産が拡大していることも、依然として成長の大きな原動力となっています。

粉末セグメントは2022年に35.4%超の最大の収益シェアを占めています。粉末状の薬用食品を商業的に容易に入手できることが、このセグメントの拡大の主な要因となっています。さらに、粉末状の製品は使いやすいため、さまざまな希少疾患に苦しむ小児および老人の患者に広く好まれ、これが引き続きこのセグメントの拡大を後押ししています。

施設販売チャネルは、2022年に41.2%超の最大の収益シェアを占めました。このセグメントには、在宅介護の現場や病院、障害者施設などが含まれます。オンライン販売セグメントは、予測期間中に最も速い速度で拡大すると予想されます。これらの販売チャネルが提供する利便性により、薬用食品のオンライン購入を選択する人が増えています。

希少疾患向け医療用食品市場レポートハイライト

2022年の市場規模は12億米ドルで、2022年から2030年にかけてCAGR5.5％で成長すると予測されています。希少疾患の有病率の増加、医療費、早期スクリーニング、希少疾患に関する認知度が、成長を促進する重要な要因の一つです

2022年の売上シェアは経口セグメントが69.5%超と圧倒的。しかし、経腸投与セグメントは、予測期間中に最も速い成長を示すと予想されます。主なプレーヤーは、このセグメントの成長に大きな役割を果たすと予想される技術的に高度な経腸栄養デバイスの開発に非常に焦点を当てています。

粉末セグメントは、2022年に35.4%超の最大の収益シェアを占めました。しかし、液体セグメントは予測期間中、最も速いCAGRで成長すると予想されます。固形製剤の摂取が制限される、または不可能であるため、小児および老人の消費者による液体製剤の採用率が上昇していることが、このセグメントの成長を促進する主な理由です。

機関販売チャネルは、2022年に41.2%超の最大の売上シェアを占めています。さまざまな希少疾患の診断と治療のために病院やその他のヘルスケアセンターを訪れる患者の数が増加していることが、引き続きこのセグメントの成長を後押ししている

その他のセグメントは、2022年に36.5%超の最大の収益シェアを占めました。低アレルギー性製品の上市が増加し、そのような製品がさまざまな処方で容易に商業的に入手できることが、このセグメントの成長をさらに後押ししています。しかし、FPIES状態は予測期間中に最も速いCAGRを示すと予想される

2022年、北米は30.6%を超える最大の収益シェアを占めました。アジア太平洋は、予測期間中に最も急成長する地域市場になると予測されています。普及率の上昇、認知度の向上、医療用食品の使用の増加、およびいくつかの主要な政府の取り組みが、引き続き成長の礎となっています。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
• 市場の定義
• 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
  • 1次調査：
• 調査範囲と前提
• データソースへのリスト

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 競合考察
• 希少疾病用の世界の医療用食品のスナップショット

第3章 世界の希少疾患向け医療用食品市場の変数、動向、および範囲

• 市場系列の見通し
  • 親会社の市場見通し
  • 関連/補助的な市場の見通し
• 浸透と成長の見通しのマッピング
• 価格分析
• ユーザー視点分析
  • 消費者行動分析
  • 市場インフルエンサー分析
• テクノロジーの展望
  • テクノロジーのタイムライン
• 規制の枠組み
  • 償還の枠組み
  • 規格とコンプライアンス
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 業界の課題
• 希少疾患向け医療用食品市場分析ツール
  • 業界分析- ポーターズ
    • サプライヤーの力
    • 買い手の交渉力
    • 代替の脅威
    • 新規参入者からの脅威
    • 競争企業間の敵対関係
  • PESTEL分析
    • 政治情勢
    • 環境情勢
    • 社会情勢
    • テクノロジー情勢
    • 法的情勢
    • 経済情勢
  • 主要な取引と戦略的提携の分析
    • 合併と買収
    • ライセンシングとパートナーシップ
  • 市場参入戦略
• COVID-19市場への影響

第4章 希少疾患向け医療用食品市場の競合分析

• 主要な市場参入企業別最近の動向と影響分析
• 競合の分類
• 会社の市況分析
• 主要企業の市場シェア分析（%）

第5章 希少疾患向け医療用食品市場：投与経路の推定・動向分析

• 定義と範囲
• 世界の希少疾患向け医療用食品市場：投与経路市場シェア分析、2022年および2030年
• オーラル
• 経腸

第6章 希少疾患向け医療用食品市場：製品の推定・動向分析

• 定義と範囲
• 世界の希少疾患向け医療用食品市場：製品市場シェア分析、2022年および2030年
• 丸薬
• 粉末
• 液体
• その他

第7章 希少疾患向け医療用食品市場：アプリケーションの推定・動向分析

• 定義と範囲
• 世界の希少疾患向け医療用食品市場：アプリケーション市場シェア分析、2022年および2030年
• フェニルケトン尿症
• 好酸球性食道炎
• FPIES
• チロシン血症
• MSUD
• ホモシスチン尿症
• その他

第8章 希少疾患向け医療用食品市場：販売チャネルの推定・動向分析

• 定義と範囲
• 世界の希少疾患向け医療用食品市場：販売チャネル市場シェア分析、2022年および2030年
• オンライン販売
• 機関販売
• 小売売上高

第9章 希少疾患向け医療用食品市場：地域別の推定・動向分析、投与経路、製品、アプリケーション、および販売チャネル別

• 世界の希少疾患向け医療用食品市場：地域の変動分析
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • ロシア
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • オーストラリア
  • ニュージーランド
  • シンガポール
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 企業プロファイル

• DANONE
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• NESTLE
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• ABBOTT
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• MEAD JOHNSON &COMPANY, LLC
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Relief Therapeutics
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Solace Nutrition
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Ajinomoto Cambrooke, Inc.
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ

List of Tables

• Table 1 List of key distributors and channel partners
• Table 2 List of key emerging companies, /technology disruptors/innovators
• Table 3 Few examples of the medical foods in the oral form
• Table 4 Few examples of the products available in powder form
• Table 5 Few examples of medical foods in the other formulations
• Table 6 Oral medical foods for orphan diseases market revenue estimates and forecasts, by products, 2016 - 2030 (USD Million)
• Table 7 Enteral medical foods for orphan diseases market revenue estimates and forecasts, by products, 2016 - 2030 (USD Million)
• Table 8 North America medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 9 North America medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 10 North America medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 11 North America medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 12 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 13 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 14 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 15 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 16 Canada medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 17 Canada medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 18 Canada medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 19 Canada medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 20 Europe medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 21 Europe medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 22 Europe medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 23 Europe medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 24 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 25 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 26 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 27 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 28 Germany medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 29 Germany medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 30 Germany medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 31 Germany medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 32 France medical foods for orphan diseases market revenue estimates and forecast, by route of administration, 2016 - 2030 (USD Million)
• Table 33 France medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 34 France medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 35 France medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 36 Spain medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 37 Spain medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 38 Spain medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 39 Spain medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 40 Italy medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 41 Italy medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 42 Italy medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 43 Italy medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 44 Russia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 45 Russia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 46 Russia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 47 Russia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 48 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 49 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 50 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 51 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 52 Japan medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 53 Japan medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 54 Japan medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 55 Japan medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 56 China medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 57 China medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 58 China medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 59 China medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 60 Australia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 61 Australia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 62 Australia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 63 Australia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 64 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 65 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 66 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 67 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 68 India medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 69 India medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 70 India medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 71 India medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 72 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 73 South Korea medical foods for orphan diseases market revenue estimates and forecast, by product, 2016 - 2030 (USD Million)
• Table 74 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 75 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 76 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 77 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 78 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 79 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 80 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 81 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 82 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 83 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 84 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 85 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 86 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 87 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 88 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 89 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 90 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 91 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 92 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 93 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 94 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 95 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 96 MEA medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 97 MEA medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 98 MEA medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 99 MEA medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 100 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 101 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 102 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 103 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 104 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 105 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 106 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 107 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 108 UAE medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
• Table 109 UAE medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
• Table 110 UAE medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
• Table 111 UAE medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
• Table 112 List of other players

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Medical foods for orphan diseases market snapshot, 2022 (USD Million)
• Fig. 5 Medical foods for orphan diseases market dynamics
• Fig. 6 Medical foods for orphan diseases market segmentation
• Fig. 7 Penetration & growth prospects mapping
• Fig. 8 Technology timeline
• Fig. 9 Medical foods for orphan diseases market driver impact
• Fig. 10 Medical foods for orphan diseases market restraints impact
• Fig. 11 Competition categorization
• Fig. 12 Key company market share analysis (%)
• Fig. 13 Company market position analysis
• Fig. 16 Medical foods for orphan diseases market: Route of administration market share analysis, 2022
• Fig. 17 Segment Dashboard
• Fig. 18 Oral medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 19 Enteral medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 20 Medical foods for orphan diseases market: Product market share analysis, 2022
• Fig. 21 Segment Dashboard
• Fig. 22 Medical foods for orphan diseases market estimates and forecasts for pills formulation, 2016 - 2030 (USD Million)
• Fig. 23 Medical foods for orphan diseases market estimates and forecasts for powder formulation, 2016 - 2030 (USD Million)
• Fig. 24 Medical foods for orphan diseases market estimates and forecasts for liquid formulation, 2016 - 2030 (USD Million)
• Fig. 25 Medical foods for orphan diseases market estimates and forecasts for other formulations, 2016 - 2030 (USD Million)
• Fig. 26 Medical foods for orphan diseases market: Application market share analysis, 2022
• Fig. 27 Segment Dashboard
• Fig. 29 Medical foods for orphan diseases market estimates and forecasts for phenylketonuria, 2016 - 2030 (USD Million)
• Fig. 30 Medical foods for orphan diseases market estimates and forecasts for eosinophilic esophagitis, 2016 - 2030 (USD Million)
• Fig. 31 Medical foods for orphan diseases market estimates and forecasts for FPIES, 2016 - 2030 (USD Million)
• Fig. 32 Medical foods for orphan diseases market estimates and forecasts for MSUD, 2016 - 2030 (USD Million)
• Fig. 33 Medical foods for orphan diseases market estimates and forecasts for Homocystinuria, 2016 - 2030 (USD Million)
• Fig. 34 Medical foods for orphan diseases market estimates and forecasts for other diseases, 2016 - 2030 (USD Million)
• Fig. 35 Medical foods for orphan diseases market: Sales channel market share analysis, 2022
• Fig. 36 Medical foods for orphan diseases market estimates and forecasts for online sales channel, 2016 - 2030 (USD Million)
• Fig. 37 Medical foods for orphan diseases market estimates and forecasts for retail sales channel, 2016 - 2030 (USD Million)
• Fig. 38 Medical foods for orphan diseases market estimates and forecasts for institutional sales channel, 2016 - 2030 (USD Million)
• Fig. 39 Regional market snapshot, 2022 & 2030, (USD Million)
• Fig. 40 Medical foods for orphan diseases market: Regional market share analysis, 2022
• Fig. 41 North America medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 42 Europe medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 43 Asia Pacific medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 44 Latin America medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 45 MEA medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 46 North America market share, by country, 2016 - 2030 (USD Million)
• Fig. 47 U.S. medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 48 Canada medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 49 Europe market share, by country, 2016 - 2030 (USD Million)
• Fig. 50 U.K. medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 51 Germany medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 52 France medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 53 Spain medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 54 Italy medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 55 Russia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 56 Asia Pacific market share, by country, 2016 - 2030 (USD Million)
• Fig. 57 Japan medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 58 China medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 59 Australia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 60 New Zealand medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 61 India medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 62 South Korea medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 63 Singapore medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 64 Latin America market share, by country, 2016 - 2030 (USD Million)
• Fig. 65 Brazil medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 66 Mexico medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 67 Argentina medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 68 MEA market share, by country, 2016 - 2030 (USD Million)
• Fig. 69 South Africa medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 70 Saudi Arabia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
• Fig. 71 UAE medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)

Medical Foods For Orphan Diseases Market Growth & Trends:

The global medical foods for orphan diseases market size is expected to reach USD 1.9 billion by 2030. It is expected to expand at a CAGR of 5.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to the industry's growth are the growing prevalence of orphan diseases and increasing awareness about such rare conditions. Moreover, rising government initiatives for early screening and increasing initiatives by key players to develop products that cater to such niche segments also spell a promising horizon of growth.

Special medical nutritional requirements are needed for a variety of rare diseases in order to prevent major disabilities and allow normal growth in children and adults. Conditions like food protein-induced maple syrup urine disease, short bowel syndrome, and others, require special dietary requirements in order to maintain robust health. The growing awareness of such rare conditions and increased efficacy of diet plans also promise more avenues for growth.

Medical foods are expensive and may or may not be covered under health insurance. Since the FDA does not classify medicinal foods as drugs, many insurance plans do not cover them. This can impede market expansion over the forecast period.

Unlike other industries, COVID-19 had a positive impact on market growth. The increased awareness about immunity and healthy foods led to a significant rise in the adoption rate of clinical foods. In the year 2020, consumers opted for much healthier diets encompassing nutritional support and dietetic care as compared to the year 2019.

The oral segment dominated the market with a revenue share of over 69.5% in 2022. The oral route for medicinal foods remains the most convenient, and hassle-free. Hence, it remains the most preferred route for consumers globally and oral products are easily available. The expanding production of oral goods in the form of tablets, powder, and pre-thickened products also remains a prominent driver of growth.

The powder segment accounted for the largest revenue share of over 35.4% in 2022. Easy commercial availability of medicinal foods in powdered form is largely responsible for the segment's expansion. Additionally, powered forms of products are simple to use and hence widely preferred by pediatric and geriatric patients suffering from various rare diseases, which continues to drive the segment's expansion.

The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The segment includes home care settings, hospitals, and disability facilities. The online sales segment is anticipated to expand at the fastest rate over the forecast period. Due to the convenience, these sales channel provides, more people choose to buy medicinal foods online.

Medical Foods For Orphan Diseases Market Report Highlights:

• The market size was valued at USD 1.2 billion in 2022 and is expected to grow at a CAGR of 5.5% from 2022 to 2030. Increasing prevalence of rare diseases, healthcare expenditure, early screening, and awareness about rare diseases are some key factors that propel the growth

• The oral segment held the dominant revenue share of over 69.5% in 2022. However, the enteral route of the administration segment is expected to showcase the fastest growth over the forecast years. Key players are highly focused on developing technologically advanced enteral feeding devices which are anticipated to play a major role in this segment's growth.

• The powder segment accounted for the largest revenue share of over 35.4% in 2022. However, the liquid segment is expected to grow at the fastest CAGR over the forecast period. The rising adoption rate of liquid formulations by pediatric and geriatric consumers, as the intake of solid formulations is restricted or unfeasible is the major reason that fuels the segment's growth

• The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The increasing number of patient visits to hospitals and other healthcare centers for the diagnosis and treatment of different orphan disorders continues to propel the growth of the segment

• The others segment accounted for the largest revenue share of over 36.5% in 2022. The increasing number of hypoallergenic product launches and easy commercial availability of such products in various formulations further boost the segment's growth. However, FPIES condition is expected to showcase the fastest CAGR over the forecast period

• In 2022, North America held the largest revenue share of over 30.6%. Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period. Increasing penetration rate, awareness, growing use of medical foods, and several key government initiatives remain the cornerstone of its growth

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation and Scope
• 1.2 Market Definition
• 1.3 Research Methodology
  • 1.3.1 Information Procurement
    • 1.3.1.1 Purchased database
    • 1.3.1.2 GVR's internal database
  • 1.3.2 Primary Research:
• 1.4 Research Scope and Assumptions
• 1.5 List to Data Sources

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights
• 2.4 Global Medical Foods for Orphan Diseases Snapshot

Chapter 3 Global Medical Foods for Orphan Diseases Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Pricing Analysis
• 3.4 User Perspective Analysis
  • 3.4.1 Consumer behavior analysis
  • 3.4.2 Market influencer analysis
• 3.5 Technology Outlook
  • 3.5.1 Technology timeline
• 3.6 Regulatory Framework
  • 3.6.1 Reimbursement framework
  • 3.6.2 Standards and compliances
• 3.7 Market Dynamics
  • 3.7.1 Market driver analysis
  • 3.7.2 Market restraint analysis
  • 3.7.3. Industry Challenges
• 3.8 Medical Foods for Orphan Diseases Market Analysis Tools
  • 3.8.1. Industry Analysis - Porter's
    • 3.8.1.1 Supplier power
    • 3.8.1.2 Buyer power
    • 3.8.1.3 Substitution threat
    • 3.8.1.4 Threat from new entrant
    • 3.8.1.5 Competitive rivalry
  • 3.8.2. PESTEL analysis
    • 3.8.2.1 Political landscape
    • 3.8.2.2 Environmental landscape
    • 3.8.2.3 Social landscape
    • 3.8.2.4 Technology landscape
    • 3.8.2.5 Legal landscape
    • 3.8.2.6 Economic landscape
  • 3.8.3 Major deals & strategic alliances analysis
    • 3.8.3.1 Mergers & acquisitions
    • 3.8.3.2 Licensing & partnership
  • 3.8.4 Market entry strategies
• 3.9 COVID-19 Impact on the market

Chapter 4 Medical Foods for Orphan Diseases Market-Competitive Analysis

• 4.1 Recent Developments & Impact Analysis, By Key Market Participants
• 4.2 Competition Categorization
• 4.3 Company Market Position Analysis
• 4.4 Key Company Market Share Analysis (%)

Chapter 5 Medical Foods for Orphan Diseases Market: Route of Administration Estimates & Trend Analysis

• 5.1 Definitions & Scope
• 5.2 Global Medical Foods for Orphan Diseases Market: Route of Administration Market Share Analysis, 2022 and 2030
• 5.3 Oral
  • 5.3.1 Oral market estimates and forecasts, 2016 - 2030 (USD Million)
• 5.4 Enteral
  • 5.4.1 Enteral market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 6 Medical Foods for Orphan Diseases Market: Product Estimates & Trend Analysis

• 6.1 Definitions & Scope
• 6.2 Global Medical Foods for Orphan Diseases Market: Product Market Share Analysis, 2022 and 2030
• 6.3 Pills
  • 6.3.1 Pills market estimates and forecasts, 2016 - 2030 (USD Million)
• 6.4 Powders
  • 6.4.1 Powders market estimates and forecasts, 2016 - 2030 (USD Million)
• 6.5 Liquid
  • 6.5.1 Liquid market estimates and forecasts, 2016 - 2030 (USD Million)
• 6.6 Others
  • 6.6.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 7 Medical Foods for Orphan Diseases Market: Application Estimates & Trend Analysis

• 7.1 Definitions & Scope
• 7.2 Global Medical Foods for Orphan Diseases Market: Application Market Share Analysis, 2022 and 2030
• 7.3 Phenylketonuria
  • 7.3.1 Phenylketonuria market estimates and forecasts, 2016 - 2030 (USD Million)
• 7.4 Eosinophilic Esophagitis
  • 7.4.1 Eosinophilic Esophagitis market estimates and forecasts, 2016 - 2030 (USD Million)
• 7.5 FPIES
  • 7.5.1 FPIES market estimates and forecasts, 2016 - 2030 (USD Million)
• 7.6 Tyrosinemia
  • 7.6.1 Tyrosinemia market estimates and forecasts, 2016 - 2030 (USD Million)
• 7.7 MSUD
  • 7.7.1 MSUD market estimates and forecasts, 2016 - 2030 (USD Million)
• 7.8 Homocystinuria
  • 7.8.1 Homocystinuria market estimates and forecasts, 2016 - 2030 (USD Million)
• 7.9 Others
  • 7.9.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 8 Medical Foods for Orphan Diseases Market: Sales Channel Estimates & Trend Analysis

• 8.1 Definitions & Scope
• 8.2 Global Medical Foods for Orphan Diseases Market: Sales Channel Market Share Analysis, 2022 and 2030
• 8.3 Online sales
  • 8.3.1 Online sales market estimates and forecasts, 2016 - 2030 (USD Million)
• 8.4 Institutional sales
  • 8.4.1 Institutional sales market estimates and forecasts, 2016 - 2030 (USD Million)
• 8.5 Retail sales
  • 8.5.1 Retail sales market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 9 Medical Foods for Orphan Diseases Market: Regional Estimates & Trend Analysis, By Route of Administration, Product, Application, and Sales Channel

• 9.1 Global Medical Foods for Orphan Diseases Market: Regional Movement Analysis
• 9.2 North America
  • 9.2.1 North America medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.2.2 U.S.
    • 9.2.2.1 U.S. medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.2.3 Canada
    • 9.2.3.1 Canada medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
• 9.3 Europe
  • 9.3.1 Europe medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3.2 U.K.
    • 9.3.2.1 U.K. medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3.3 Germany
    • 9.3.3.1 Germany medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3.4 France
    • 9.3.4.1 France medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3.5 Spain
    • 9.3.5.1 Spain medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3.6 Italy
    • 9.3.6.1 Italy medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3.7 Russia
    • 9.3.7.1 Russia medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
• 9.4 Asia Pacific
  • 9.4.1 Asia pacific medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4.2 China
    • 9.4.2.1 China medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4.3 Japan
    • 9.4.3.1 Japan medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4.4 India
    • 9.4.4.1 India medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4.5 Australia
    • 9.4.5.1 Australia medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4.6 New Zealand
    • 9.4.6.1 New Zealand medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4.7 Singapore
    • 9.4.7.1 Singapore medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4.8 South Korea
    • 9.4.8.1 South Korea medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
• 9.5 Latin America
  • 9.5.1 Latin America medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.5.2 Brazil
    • 9.5.2.1 Brazil medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.5.3 Mexico
    • 9.5.3.1 Mexico medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.5.4 Argentina
    • 9.5.4.1 Argentina medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
• 9.6 MEA
  • 9.6.1 MEA medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.6.2 South Africa
    • 9.6.2.1 South Africa medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.6.3 Saudi Arabia
    • 9.6.3.1 Saudi Arabia medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.6.4 UAE
    • 9.6.4.1 UAE medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)

Chapter 10 Company Profiles

• 10.1 DANONE
  • 10.1.1 Company overview
  • 10.1.2 Financial performance
  • 10.1.3 Product benchmarking
  • 10.1.4 Strategic initiatives
• 10.2 NESTLE
  • 10.2.1 Company overview
  • 10.2.2 Financial performance
  • 10.2.3 Product benchmarking
  • 10.2.4 Strategic initiatives
• 10.3 ABBOTT
  • 10.3.1 Company overview
  • 10.3.2 Financial performance
  • 10.3.3 Product benchmarking
  • 10.3.4 Strategic initiatives
• 10.4 MEAD JOHNSON & COMPANY, LLC
  • 10.4.1 Company overview
  • 10.4.2 Financial performance
  • 10.4.3 Product benchmarking
  • 10.4.4 Strategic initiatives
• 10.5 Relief Therapeutics
  • 10.5.1 Company overview
  • 10.5.2 Financial performance
  • 10.5.3 Product benchmarking
  • 10.5.4 Strategic initiatives
• 10.6 Solace Nutrition
  • 10.6.1 Company overview
  • 10.6.2 Financial performance
  • 10.6.3 Product benchmarking
  • 10.6.4 Strategic initiatives
• 10.7 Ajinomoto Cambrooke, Inc.
  • 10.7.1 Company overview
  • 10.7.2 Financial performance
  • 10.7.3 Product benchmarking
  • 10.7.4 Strategic initiatives